Organization: Health Canada
Year: 2023
Month: November
Request Number: A-2023-000994
Request Summary: The Section 1.0.7 “Note to the Reviewer” (Module 1.0.7) from the generic manufacturer of the Estradiol Abbreviated New Drug Submission (ANDS) which appears on the Generic Submissions Under Review (GSUR) List.
Disposition: No records exist
Number of pages: 0